 BATON ROUGE, La., Dec. 23, 2020 GLOBE NEWSWIRE -- Amedisys, Inc. NASDAQ: AMED, Americas leading independent home health, hospice and personal care company, today announced that its Board of Directors has authorized a stock repurchase program, under which the Company may repurchase up to 100 million of its outstanding common stock through December 31, 2021. 